Moreover, only one study has assessed plasma levels of soluble CD40 ligand (sCD40L), reporting higher concentrations in RHD patients with moderate-to-severe mitral stenosis compared to healthy controls [35]. This evidence concerns the gene CD40LG and rheumatic heart disease.